SpiroChem Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$605K
- Investors
-
3
SpiroChem General Information
Description
Operator of a discovery and chemistry contract research organization intended to accelerate drug discovery and lead optimization programs. The company offers proprietary screening of covalent fragments and macrocycles, fragment-based drug designing, and computational-aided drug design services, enabling the biotechnology, pharmaceutical, agrochemical, and life science companies to speed up research programs and explore uncharted chemical space.
Contact Information
Website
www.spirochem.comCorporate Office
- Rosental Area, WRO-1047-3
- Mattenstrasse 22
- 4058 Basel
- Switzerland
Corporate Office
- Rosental Area, WRO-1047-3
- Mattenstrasse 22
- 4058 Basel
- Switzerland
SpiroChem Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 21-Jun-2021 | $605K | Completed | Generating Revenue | ||
| 5. Later Stage VC | 13-Dec-2017 | Completed | Startup | |||
| 4. Grant | 26-Jan-2016 | Completed | Startup | |||
| 3. Seed Round | 10-Sep-2013 | Completed | Startup | |||
| 2. Grant | 25-May-2011 | $11.4K | Completed | Startup | ||
| 1. University Spin-Out | 01-Jan-2011 | Completed | Startup |
SpiroChem Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SpiroChem Comparisons
Industry
Financing
Details
SpiroChem Competitors (11)
One of SpiroChem’s 11 competitors is Solvias, a Private Equity-Backed company based in Kaiseraugst, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Solvias | Private Equity-Backed | Kaiseraugst, Switzerland | ||||
| Crown Bioscience | Formerly VC-backed | San Diego, CA | ||||
| Buffalo Biolabs | Corporation | Buffalo, NY | ||||
| Taconic Biosciences | Private Equity-Backed | Rensselaer, NY | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA |
SpiroChem Patents
SpiroChem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240051933-A1 | Urolithin derivatives and therapeutic uses | Pending | 27-Jul-2022 | ||
| US-11820751-B2 | Urolithin derivatives and methods of use thereof | Active | 27-Jan-2021 | ||
| US-12351567-B2 | Urolithin derivatives and methods of use thereof | Active | 27-Jan-2021 | ||
| US-12358884-B2 | Urolithin derivatives and methods of use thereof | Active | 27-Jan-2021 | ||
| US-20220259173-A1 | Urolithin derivatives and methods of use thereof | Active | 27-Jan-2021 | C07D311/80 |
SpiroChem Signals
SpiroChem Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Swiss Government | Government | |||
| Venture Kick | Accelerator/Incubator | |||
| ETH Zurich | University |
SpiroChem Acquisitions (1)
SpiroChem’s most recent deal was a Merger/Acquisition with Cyclenium Pharma. The deal was made on 06-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cyclenium Pharma | 06-Jun-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
SpiroChem Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cyclenium Pharma | Montreal, Canada | 2013 |
SpiroChem FAQs
-
When was SpiroChem founded?
SpiroChem was founded in 2011.
-
Where is SpiroChem headquartered?
SpiroChem is headquartered in Basel, Switzerland.
-
What is the size of SpiroChem?
SpiroChem has 120 total employees.
-
What industry is SpiroChem in?
SpiroChem’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is SpiroChem a private or public company?
SpiroChem is a Private company.
-
What is the current valuation of SpiroChem?
The current valuation of SpiroChem is .
-
What is SpiroChem’s current revenue?
The current revenue for SpiroChem is .
-
How much funding has SpiroChem raised over time?
SpiroChem has raised $1.03M.
-
Who are SpiroChem’s investors?
Swiss Government, Venture Kick, and ETH Zurich have invested in SpiroChem.
-
Who are SpiroChem’s competitors?
Solvias, Crown Bioscience, Buffalo Biolabs, Taconic Biosciences, and Charles River Laboratories International are some of the 11 competitors of SpiroChem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process